Thompson Siegel & Walmsley’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.2M | Sell |
72,426
-2,076
| -3% | -$447K | 0.33% | 88 |
|
|
2026
Q1 | $16.2M | Buy |
74,502
+222
| +0.3% | +$49.2K | 0.28% | 89 |
|
|
2025
Q4 | $17M | Buy |
74,280
+211
| +0.3% | +$48.1K | 0.28% | 94 |
|
|
2025
Q3 | $17.1M | Buy |
74,069
+37
| +0% | +$7.54K | 0.28% | 95 |
|
|
2025
Q2 | $13.7M | Buy |
74,032
+577
| +0.8% | +$107K | 0.23% | 102 |
|
|
2025
Q1 | $15.4M | Buy |
73,455
+169
| +0.2% | +$32.9K | 0.26% | 96 |
|
|
2024
Q4 | $13M | Sell |
73,286
-53
| -0.1% | -$9.74K | 0.2% | 119 |
|
|
2024
Q3 | $14.5M | Buy |
73,339
+710
| +1% | +$133K | 0.22% | 103 |
|
|
2024
Q2 | $12.5M | Buy |
72,629
+39
| +0.1% | +$6.46K | 0.2% | 112 |
|
|
2024
Q1 | $13.2M | Sell |
72,590
-75
| -0.1% | -$12.9K | 0.2% | 110 |
|
|
2023
Q4 | $11.3M | Sell |
72,665
-40
| -0.1% | -$5.83K | 0.18% | 120 |
|
|
2023
Q3 | $10.8M | Sell |
72,705
-30
| -0% | -$4.4K | 0.18% | 121 |
|
|
2023
Q2 | $9.8M | Hold |
72,735
| – | – | 0.16% | 138 |
|
|
2023
Q1 | $11.6M | Sell |
72,735
-6
| -0% | -$917 | 0.19% | 119 |
|
|
2022
Q4 | $11.8M | Sell |
72,741
-766
| -1% | -$117K | 0.19% | 122 |
|
|
2022
Q3 | $9.87M | Sell |
73,507
-23,150
| -24% | -$3.32M | 0.17% | 134 |
|
|
2022
Q2 | $14.8M | Sell |
96,657
-6,444
| -6% | -$985K | 0.24% | 106 |
|
|
2022
Q1 | $16.7M | Sell |
103,101
-26
| -0% | -$3.78K | 0.24% | 111 |
|
|
2021
Q4 | $14M | Buy |
103,127
+17,500
| +20% | +$2.07M | 0.19% | 129 |
|
|
2021
Q3 | $9.24M | Buy |
85,627
+7,125
| +9% | +$814K | 0.13% | 154 |
|
|
2021
Q2 | $8.84M | Sell |
78,502
-1,432
| -2% | -$161K | 0.12% | 150 |
|
|
2021
Q1 | $8.65M | Sell |
79,934
-878
| -1% | -$93.9K | 0.12% | 145 |
|
|
2020
Q4 | $8.66M | Sell |
80,812
-2,433
| -3% | -$234K | 0.14% | 142 |
|
|
2020
Q3 | $7.29M | Sell |
83,245
-28,942
| -26% | -$2.72M | 0.14% | 136 |
|
|
2020
Q2 | $11M | Buy |
112,187
+35,956
| +47% | +$3.17M | 0.22% | 109 |
|
|
2020
Q1 | $5.81M | Buy |
76,231
+25,517
| +50% | +$2.17M | 0.14% | 131 |
|
|
2019
Q4 | $4.49M | Buy |
50,714
+15,491
| +44% | +$1.29M | 0.07% | 173 |
|
|
2019
Q3 | $2.67M | Buy |
35,223
+3,906
| +12% | +$268K | 0.04% | 187 |
|
|
2019
Q2 | $2.28M | Buy |
31,317
+828
| +3% | +$65.1K | 0.03% | 196 |
|
|
2019
Q1 | $2.46M | Sell |
30,489
-19,422
| -39% | -$1.59M | 0.03% | 193 |
|
|
2018
Q4 | $4.6M | Sell |
49,911
-6,000
| -11% | -$528K | 0.07% | 166 |
|
|
2018
Q3 | $5.29M | Sell |
55,911
-175
| -0.3% | -$16.6K | 0.07% | 173 |
|
|
2018
Q2 | $5.2M | Buy |
56,086
+550
| +1% | +$53.7K | 0.07% | 184 |
|
|
2018
Q1 | $5.26M | Sell |
55,536
-4,600
| -8% | -$505K | 0.06% | 216 |
|
|
2017
Q4 | $5.82M | Buy |
60,136
+1,846
| +3% | +$174K | 0.07% | 215 |
|
|
2017
Q3 | $5.18M | Sell |
58,290
-10,107
| -15% | -$769K | 0.06% | 228 |
|
|
2017
Q2 | $4.96M | Hold |
68,397
| – | – | 0.06% | 237 |
|
|
2017
Q1 | $4.46M | Buy |
68,397
+15,820
| +30% | +$995K | 0.05% | 254 |
|
|
2016
Q4 | $3.29M | Buy |
52,577
+44,693
| +567% | +$2.73M | 0.04% | 245 |
|
|
2016
Q3 | $497K | Sell |
7,884
-484
| -6% | -$31.3K | 0.01% | 341 |
|
|
2016
Q2 | $518K | Sell |
8,368
-28
| -0.3% | -$1.71K | 0.01% | 324 |
|
|
2016
Q1 | $480K | Buy |
8,396
+1,000
| +14% | +$55.7K | 0.01% | 320 |
|
|
2015
Q4 | $438K | Sell |
7,396
-250
| -3% | -$14.4K | 0.01% | 332 |
|
|
2015
Q3 | $416K | Buy |
7,646
+48
| +0.6% | +$3.13K | 0.01% | 339 |
|
|
2015
Q2 | $511K | Sell |
7,598
-31
| -0.4% | -$2.02K | 0.01% | 329 |
|
|
2015
Q1 | $447K | Sell |
7,629
-219
| -3% | -$13.2K | 0.01% | 336 |
|
|
2014
Q4 | $514K | Buy |
7,848
+267
| +4% | +$16.8K | 0.01% | 330 |
|
|
2014
Q3 | $438K | Buy |
7,581
+290
| +4% | +$16.1K | 0.01% | 329 |
|
|
2014
Q2 | $412K | Sell |
7,291
-2,014
| -22% | -$106K | 0.01% | 341 |
|
|
2014
Q1 | $478K | Sell |
9,305
-1,376
| -13% | -$69.5K | 0.01% | 330 |
|
|
2013
Q4 | $564K | Sell |
10,681
-5,846
| -35% | -$287K | 0.01% | 315 |
|
|
2013
Q3 | $739K | Sell |
16,527
-4,625
| -22% | -$205K | 0.02% | 295 |
|
|
2013
Q2 | $874K | Buy |
+21,152
| New | +$925K | 0.02% | 291 |
|
Other funds holding ABBV
Thompson Siegel & Walmsley's ABBV Position: Q2 2026 in Review
Thompson Siegel & Walmsley reduced its AbbVie (ABBV) stake by 2.8% in Q2 2026, selling an estimated $447K and leaving 72,426 shares worth $18.2M. The position accounts for 0.33% of the portfolio, ranked #88.
Thompson Siegel & Walmsley first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Thompson Siegel & Walmsley held 72,426 shares of AbbVie worth $18.2M as of Q2 2026.
- Thompson Siegel & Walmsley sold 2,076 AbbVie shares in Q2 2026, an estimated $447K.
- AbbVie made up 0.33% of Thompson Siegel & Walmsley's portfolio in Q2 2026, its #88 holding.
- Thompson Siegel & Walmsley first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.